The proposed 1,400-strong firm will combine Taylor Wessing's top UK and European practice with Winston & Strawn's US-focused ...

The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory ...

The lateral hire from Covington & Burling will strengthen the firm's cross-border expertise as the UK and EU markets ...

24 December 2024 Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | ...

The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster ...

Solicitor General urges the US Supreme Court to hear an appeal in its dispute, arguing that a ruling threatens the future of ...

The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple ...

A Finnish wearable fitness gadget company has lost its bid to overturn the invalidation of a key patent, with the US Federal ...

The Delhi High Court has denied an injunction against an Indian generic manufacturer, finding credible challenges to the ...

11 March 2025 The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of ...

The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a ...

18 January 2024 The office delivered its final written decision in favour of Daiichi Sankyo in a patent clash with ...